Literature DB >> 15936594

Control of melanoma cell invasion by type IV collagen.

Sylvie Pasco1, Bertrand Brassart, Laurent Ramont, François-Xavier Maquart, Jean-Claude Monboisse.   

Abstract

Malignant melanoma is the leading cause of death from diseases of the skin. This review summarizes the data from the literature and our laboratory addressing the effects of type IV collagen on melanoma progression. Many different sequences from type IV collagen promote melanoma cell adhesion, migration and invasion. The triple helical conformation of the collagenous domain plays a critical role in some of these interactions. However, recent studies from our group demonstrated that a sequence from the alpha3(IV) NC1 domain inhibits melanoma cell proliferation, migration and invasion by decreasing MMP production and activation. Peptide sequences from the alpha1(IV), alpha2(IV) and alpha3(IV) chains named arresten, canstatin and tumstatin, respectively were shown to inhibit angiogenesis. Further investigations regarding the inhibitory effects of the alpha(IV) NC1 domains will have a paramount relevance for the design of efficient strategies to limit melanoma development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15936594     DOI: 10.1016/j.cdp.2004.09.003

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  19 in total

1.  Characterization of a non-fibrillar-related collagen in the mollusc Haliotis tuberculata and its biological activity on human dermal fibroblasts.

Authors:  Christophe Fleury; Antoine Serpentini; Magdalini Kypriotou; Emmanuelle Renard; Philippe Galéra; Jean-Marc Lebel
Journal:  Mar Biotechnol (NY)       Date:  2011-01-27       Impact factor: 3.619

2.  Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions.

Authors:  Qin Zhao; Zhi-dong Liu; Yong Xue; Jing-feng Wang; Hui Li; Qing-juan Tang; Yu-ming Wang; Ping Dong; Chang-hu Xue
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

3.  Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor.

Authors:  Jose L Orgaz; Alberto Benguria; Cristina Sanchez-Martinez; Omar Ladhani; Olga V Volpert; Benilde Jimenez
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

4.  Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.

Authors:  Venugopal Gunda; Yakkanti A Sudhakar
Journal:  J Cancer Sci Ther       Date:  2013-07-04

5.  Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.

Authors:  Deepa Jagtap; Carol A Rosenberg; Lisa W Martin; Mary Pettinger; Janardan Khandekar; Dorothy Lane; Ira Ockene; Michael S Simon
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

6.  Tumstatin 185-191 increases the sensitivity of non-small cell lung carcinoma cells to cisplatin by blocking proliferation, promoting apoptosis and inhibiting Akt activation.

Authors:  Wei Wang; Ping Chen; Min Tang; Junli Li; Yanfang Pei; Shan Cai; Xiao Zhou; Senlin Chen
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

7.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Update on the Epidemiology of Melanoma.

Authors:  Steven T Chen; Alan C Geller; Hensin Tsao
Journal:  Curr Dermatol Rep       Date:  2013-03-01

9.  Chloride intracellular channel 1 functions in endothelial cell growth and migration.

Authors:  Jennifer J Tung; Jan Kitajewski
Journal:  J Angiogenes Res       Date:  2010-11-01

10.  Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Gene Regul Syst Bio       Date:  2007-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.